Biosimilar Patent Disputes — An Update On The Last 8 Months

Last September, our Law360 Expert Analysis piece, "Biosimilar Patent Disputes: What Sandoz Appeal May Clarify," brought readers current on the legal guidance to date on scope and exclusivity of the statutory...

Already a subscriber? Click here to view full article